4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-17-015990
VP, Finance sold 161 shares at $2.56 ($412)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Selby Brian L. VP, Finance | 2017-02-27 | Sale | −161 | $2.56 | $412 | 2,389 | D |
| Derivatives | |||||||
| Selby Brian L. VP, Finance | 2017-02-27 | Grant or award · Stock Option (right to buy) | +24,100 | 24,100 | D | ||
| Open-market sales · 161 sh · avg $2.56 · $412 | |||||||
Loading xslF345X03/doc4.xml…